Friedrich Graf Finckenstein

2019

In 2019, Friedrich Graf Finckenstein earned a total compensation of $3.4M as Chief Medical Officer at Lion Biotechnologies.

Compensation breakdown

Bonus$160,000
Non-Equity Incentive Plan$82,500
Option Awards$2,655,440
Salary$450,000
Other$11,200
Total$3,359,140

Finckenstein received $2.7M in option awards, accounting for 79% of the total pay in 2019.

Finckenstein also received $160K in bonus, $82.5K in non-equity incentive plan, $450K in salary and $11.2K in other compensation.

Rankings

In 2019, Friedrich Graf Finckenstein's compensation ranked 3,645th out of 13,971 executives tracked by ExecPay. In other words, Finckenstein earned more than 73.9% of executives.

ClassificationRankingPercentile
All
3,645
out of 13,971
74th
Division
Manufacturing
1,317
out of 5,701
77th
Major group
Chemicals And Allied Products
457
out of 2,200
79th
Industry group
Drugs
383
out of 1,886
80th
Industry
Biological Products, Except Diagnostic Substances
85
out of 389
78th
Source: SEC filing on April 27, 2021.

Finckenstein's colleagues

We found three more compensation records of executives who worked with Friedrich Graf Finckenstein at Lion Biotechnologies in 2019.

2019

Maria Fardis

Lion Biotechnologies

Chief Executive Officer

2019

Frederick Vogt

Lion Biotechnologies

General Counsel

2019

Timothy Morris

Lion Biotechnologies

Chief Financial Officer

News

In-depth

You may also like